JLHL
NSEPrice History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Mixed MA signals — sideways/transition
Price Action
Support & Resistance Levels
Volume Analysis
Recent MA Crossovers
Stop Loss Levels
Fixed Risk
Technical Levels
Moving Averages
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹325.4 Cr | ₹347.6 Cr | ₹393.6 Cr | ₹365.4 Cr |
| Net Profit | ₹44.9 Cr | ₹43.8 Cr | ₹57.5 Cr | ₹42.6 Cr |
| EPS | — | ₹6.69 | ₹8.75 | ₹5.49 |
| Operating Profit | ₹78.1 Cr | ₹91 Cr | ₹103.5 Cr | ₹86.2 Cr |
Peer Comparison
HospitalPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| APOLLOHOSP | Apollo Hospitals Enterprise Limited | ₹8,498.00 | +0.06% |
| MAXHEALTH | Max Healthcare Institute Limited | ₹1,012.45 | +0.28% |
| FORTIS | Fortis Healthcare Limited | ₹990.35 | +0.14% |
| ASTERDM | Aster DM Healthcare Limited | ₹814.95 | +0.15% |
| NH | Narayana Hrudayalaya Ltd. | ₹1,893.90 | +1.90% |
| MEDANTA | Global Health Limited | ₹1,235.10 | +0.49% |
| KIMS | Krishna Institute of Medical Sciences Limited | ₹785.10 | +2.57% |
| AGARWALEYE | Dr. Agarwal's Health Care Limited | ₹439.75 | +0.08% |
| RAINBOW | Rainbow Childrens Medicare Limited | ₹1,365.00 | +1.87% |
| PARKHOSPS | Park Medi World Limited | ₹274.60 | +0.49% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 22 May 2026 | Interim Dividend - Re 1 Per Share | INTERIM_DIVIDEND |
| 04 Jul 2025 | Dividend - Re 1 Per Share | DIVIDEND |
| 02 Aug 2024 | Dividend - Re 1 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for JLHL
View All
Analysts project up to 17% upside in healthcare stocks trading at new highs
Apollo Hospitals, Aster DM Healthcare, Sai Life Sciences have rallied up to 27% thus far in FY27; technical analysts remain bullish on these stocks given the favourable chart set-up.
7 most valued firms' mcap eroded ₹1.25 trn last week, RIL took biggest hit
The combined market valuation of seven of the top-10 most-valued firms eroded by Rs 1.25 lakh crore last week, with Reliance Industries taking the biggest hit, in-line with a bearish trend in equities. Last week, the BSE benchmark Sensex declined 532.4 points, or 0.71 per cent, and the NSE Nifty dipped 181.05 points, or 0.76 per cent. "Persistent FII selling remained the key drag on market sentiment despite supportive developments such as cooling crude oil prices and a recovery in the rupee against the US dollar. Concerns regarding the pace of monsoon advancement also weighed on investor confidence," Santosh Meena, Head of Research at Swastika Investmart Ltd, said. From the top-10 pack, Reliance Industries, Bharti Airtel, Tata Consultancy Services (TCS), Bajaj Finance, Larsen & Toubro, Life Insurance Corporation of India (LIC) and Hindustan Unilever faced erosion from their valuation, while HDFC Bank, ICICI Bank, and State Bank of India were the gainers. The market valuation of ...
Hospitals warn Central Government Health Scheme reimbursement cap may hurt cancer treatment
A major private hospital group warns of a crisis for advanced cancer patients under the Central Government Health Scheme. A reimbursement cap on life-saving immunotherapy drugs is creating financial strain for hospitals. This policy threatens patient access to essential treatments. The association has identified nine specific drugs that are now out of reach for many beneficiaries.